medigraphic.com
Academia Mexicana de Neurología, A.C.

2014, Number 1

<< Back

Rev Mex Neuroci 2014; 15 (1)

Guillain-Barré syndrome following thrombolysis with rtPA in acute

Parada-Garza JD, Ruiz-Herrera VV, Chiquete E, Luquín S, Ruiz-Sandoval JL

Language: Spanish
References: 32
Page: 54-57
PDF size: 142.40 Kb.


ABSTRACT

Introduction: Guillain-Barré syndrome (GBS) has been associated with various conditions, infectious agents, lymphoproliferative disorders, trauma, recent surgery, acute myocardial infarction and application of immunological drugs. Its association with the use of tissue plasminogen activator (rtPA) is extremely rare.
Case Report: A 53-year-old man was admitted to the emergency room for a stroke in the territory of the right middle cerebral artery, with 2 hours of evolution and NIHSS of 7 points. After discarding intraparenchymal hemorrhage by head CT, the pattient received thrombolysis with rtPA. At 24 hours a control head CT showed an infarct with hemorrhagic transformation, without neurological repercussion. The patient was discharged after 96 hours with NIHSS of 5 points. On the ninth day after discharge the patient returned to the emergency room with generalized weakness, dysphagia, and progressive respiratory distress of 24 hours of evolution, requiring invasive mechanical ventilation upon arrival. At 48 hours it was documenteda right VI nerve paresis, bilateral VII nerve palsy, quadriplegia and areflexia. An MRI showed a right temporo-parietal subacute ischemic stroke with hemorrhagic transformation without evidence of brain stem infarction. Nerve conduction studies were abnormal, showing motor axonal and demyelinating polyneuropathy. The patient underwent 5 sessions of plasmapheresis without improvement.
Conclusión: This case could point to an association between thrombolytic use and GBS. However, it is necessary to wait for many other reports before this association is considered epidemiologically sound. The rare risk of GBS after thrombolysis should not be an impediment to timely reperfusion of a patient with a stroke through the use of rtPA.


REFERENCES

  1. Gensicke H, Datta AN, Dill P, Schindler C, Fischer D. Increased incidence of Guillain-Barré syndrome after surgery. Eur J Neurol 2012; 19: 1239-44.

  2. De Freitas GR, De Freitas MR, Ferreira MC. Guillain-Barré syndrome and head trauma. Arq Neuropsiquiatr 1997; 55: 315-8.

  3. Duncan R, Kennedy PG. Guillain-Barré syndrome following acute head trauma. Postgrad Med J 1987; 63: 479-80.

  4. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-50.

  5. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012; 366: 2294-304.

  6. McDonagh AJ, Dawson J. Guillain-Barré syndrome after myocardial infarction. Br Med J 1987; 294: 613-4.

  7. Ng E, Stafford PJ. Guillain-Barré syndrome after myocardial infarction. Int J Cardiol 2003; 90: 129-30.

  8. Cheng J, KahnDE, Wang MY. The acute motor-sensory axonal neuropathy variant of Guillain-Barré syndrome after thoracic spine surgery. J Neurosurg Spine 2011; 15: 605-9.

  9. Son DW, Song GS, Sung SK, Kim SH. Guillain-Barré syndrome following spinal fusion for thoracic vertebral fracture. J Korean Neurosurg Soc 2011; 50: 464-7.

  10. Foubert-Samier A, Penchet G, Yekhlef F, Lemasson G, Sibon I. Guillain-Barré syndrome secondary to cranial surgery: direct or fortuitous relationship? Neurochirurgie 2005; 51: 604-6.

  11. Puertas-Muñoz I, Miranda-Lloret P, Lagares A, Ramos-González A. Guillain-Barré syndrome following resection of glioblastoma multiforme. Rev Neurol 2004; 39: 1137-9.

  12. McCabe PH, Blakeslee MA, Tenser RB. Guillain-Barré syndrome after thalamotomy for tremor in MS. Neurology 1998; 5: 1229-30.

  13. Riebel GD, Heller JG, Hopkins LC. Guillain-Barré syndrome after an operation on the spine. A case report. J Bone Joint Surg Am 1995; 77: 1565-7.

  14. Bersano A, Santoro D, Prelle A, Lanfranconi S, Ranieri M, Tadeo CS, Bresolin N, Baron PL.Guillain–Barré syndrome after rtPA therapy for acute stroke. Neurol Sci 2010; 31: 867-9.

  15. Kaiser R, Kaufmann R, Czygan M, Lang H, Lücking CH. Guillain- Barré syndrome following streptokinase therapy. Clin Investig 1993; 71: 795-801. Tabla 1. Hallazgos clínicos y paraclínicos en pacientes con SGB asociados con el uso de trombolíticos. Autor y año Género/edad Indicación del Trombolítico Días entre Hallazgos electro- LCR Tratamiento Evolución trombolítico trombolítico Fisiológicos (células/proteí- al egreso y síntomas nas en mg/dL) hospitalario neurológicos Eden KV, 1983 M/55 Trombosis venosa Estreptoquinasa 11 No especificado - Prednisona Buena de miembro torácico derecho Leaf DA, 1984 M/65 IAM Estreptoquinasa 9 Desmielinizante 6/293 No especificado Regular motor Cicale M, 1987 M/73 TEP Estreptoquinasa 13 Desmielinizante 2/80 Plasmaféresis Regular sensori-motor Roquer J, 1990 M/55 IAM Estreptoquinasa 15 Desmielinizante 0/126 No especificado Buena sensori-motor Barnes D, 1992 M/45 IAM Estreptoquinasa 21 Desmielinizante 0/2000 Plasmaféresis Buena motor Kaiser R, 1993 M/63 IAM Estreptoquinasa 9 Desmielinizante y 1/ 1400 Prednisolona Buena axonal Ancillo P, 1994 M/58 IAM Anistreplasa 15 Desmielinizante 0/235 Metilpredniso- Muerte sensori-motor lona Taylor VE, 1995 - IAM Estreptoquinasa - - - - - - TEP Estreptoquinasa - - - - - Eshraghian A, 2010 M/70 IAM Estreptoquinasa 12 Desmielinizante 4/90 Plasmaféresis, Buena sensori-motor IGIV Buena Okuyan E, 2010 M/52 IAM Estreptoquinasa 18 Desmielinizante -/216 IGIV Buena sensori-motor Bersano A, 2010 F/71 Infarto cerebral Alteplasa 30 Desmielinizante 6/377 IGIV Buena motor Presente caso M/53 Infarto cerebral Alteplasa 8 Desmielinizante y - Plasmaféresis Muerte axonal motor Parada-Garza JD, et al. Guillain-Barré y rtPA Rev Mex Neuroci Enero-Febrero, 2014; 15(1): 54-57 57

  16. Cicale MJ. Guillain-Barré syndrome after streptokinase therapy. South Med J 1987; 80: 1068.

  17. Okuyan E, Cakar MA, Dinckal MH. Guillain-Barré syndrome after thrombolysis with streptokinase. Cardiol Res Pract 2010: 315856.

  18. Eshraghian A, Eshraghian H, Aghasadeghi K. Guillain-Barré syndrome after streptokinase therapy for acute myocardial infarction. Intern Med 2010; 49: 2445-6.

  19. Roquer J, Herraiz J, Arnau D, Serrat R. Guillain-Barré therapy syndrome after streptokinase. Acta Neurol Scand 1990; 82: 153.

  20. Eden KV. Possible association of Guillain-Barré syndrome with thrombolytic therapy. JAMA 1983; 249: 2020-1.

  21. Leaf DA, MacDonald I, Kliks B, Wilson R, Jones SR. Streptokinase and the Guillain-Barré syndrome. Ann Intern Med 1984; 100: 617.

  22. Barnes D, Hughes RA. Guillain-Barré syndrome after treatment with streptokinase. Br Med J 1992; 304: 1225.

  23. Taylor BV, Mastaglia FL, Stell R. Guillain-Barré syndrome complicating treatment with streptokinase. Med J Aust 1995; 162: 214-5.

  24. Arrowsmith JB, Milstien JB, Kuritsky JN, Murano G. Streptokinase and the Guillain-Barré syndrome. Ann Intern Med 1985; 103: 302.

  25. Ancillo P, Duarte J, Cortina JJ, Sempere AP, Clavería LE. Guillain- Barré syndrome after acute myocardial infarction treated with anistreplase. Chest 1994; 105: 1301-2.

  26. Prüss H, Iggena D, Baldinger T, Prinz V, Meisel A, Endres M, Dirnagl U, et al. Evidence of intrathecal immunoglobulin synthesis in stroke: a cohort study. Arch Neurol 2012; 69: 714-7.

  27. Linnik W, Tintinalli JE, Ramos R. Associated reactions during and immediately after rtPA infusion. Ann Emerg Med 1989; 18: 234-9.

  28. Zwickl CM, Hughes BL, Piroozi KS, Smith HW, Wierda D. Immunogenicity of tissue plasminogen activators in rhesus monkeys: antibody formation and effects on blood level and enzymatic activity. Fundam Appl Toxicol 1996; 30: 243-54.

  29. Katsutani N, Yoshitake S, Takeuchi H, Kelliher JC, Couch RC, Shionoya H. Immunogenic properties of structurally modified human tissue plasminogen activators in chimpanzees and mice. Fundam Appl Toxicol 1992; 19: 555-62.

  30. Rudolf J, Grond M, Prince WS, Schmülling S, Heiss WD. Evidence of anaphylaxy after alteplase infusion. Stroke 1999; 30: 1142-3.

  31. http://www.actilyse.com/wcms_pm/actilyse_com_prod/com/Main/ efficacy/adverse_reactions/side_effects/index.htm

  32. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León- Jiménez C, Arauz A, Villarreal-Carega J, et al. Acute care and oneyear outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol 2010; 51: 641-9.




2020     |     www.medigraphic.com